TPS Treatment for other forms of dementia
Transcranial Pulse Stimulation (TPS) – Indication: Other forms of dementia
To date, around 400 different forms of dementia are known. This variety reflects the different causes and symptoms associated with each specific form. These include both more common and less common forms caused by different disease mechanisms and brain changes. Alongside Alzheimer’s dementia, vascular dementia is the second most common form of dementia, accounting for around 20 percent of dementia sufferers. It is caused by circulatory disorders in the brain resulting from damaged blood vessels. Specific subtypes include multi-infarct dementia, strategic single-infarct dementia and subcortical arteriosclerotic encephalopathy (Binswanger’s disease). Typical symptoms include neurological signs such as hemiplegia, problems with coordination and speech disorders.
Furthermore, dementia in Parkinson’s disease, which about one third of Parkinson’s patients develop, Lewy body dementia (also known as Lewy body dementia), which is characterized by the presence of Lewy bodies in the brain, Frontotemporal dementia (FTD), which is often diagnosed in younger people (40 to 60 years) and, much less frequently, Korsakov’s syndrome, which is usually associated with alcohol abuse, and Creutzfeldt-Jakob disease. This is a very rare and rapidly progressive dementia disease that causes neurological symptoms such as myoclonus and coordination problems and is known for its rapid progression with a typical life expectancy of just one year after diagnosis.
TPS Treatment for other forms of dementia: Goals and possibilities of TPS therapy
Transcranial Pulse Stimulation (TPS) has also been shown in many cases to have a positive influence on the degradation of mental performance in other forms of dementia. In clinics and practices, dementia diseases are currently treated as “off-label” therapies in individual cases. In particular, dementia with Parkinson’s disease – which can lead to an improvement in the symptoms of both diseases – as well as Lewy body dementia and frontotemporal dementia can respond well to TPS therapy in individual cases. Clinical research supports the evidence of the benefits of TPS through further scientific work.
